Updated on 2023/09/27

写真a

 
SATO Takahiko
 
Organization
Nagoya University Hospital Hematology Assistant Professor
Title
Assistant Professor

Degree 1

  1. 学士(医学) ( 2012.3   名古屋大学 ) 

Research Areas 2

  1. Life Science / Hematology and medical oncology

  2. Life Science / Immunology

Professional Memberships 4

  1. 日本内科学会

  2. 日本血液学会

  3. 日本造血・免疫細胞療法学会

  4. 日本癌学会

 

Papers 14

  1. Autologous peripheral blood stem cell transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemia is safe but poses challenges for long-term maintenance of molecular remission: Results of the Auto-Ph17 study.

    Nishiwaki S, Sugiura I, Sato T, Kobayashi M, Osaki M, Sawa M, Adachi Y, Okabe M, Saito S, Morishita T, Kohno A, Nishiyama T, Iida H, Kurahashi S, Kuwatsuka Y, Sugiyama D, Ito S, Nishikawa H, Kiyoi H

    EJHaem   Vol. 4 ( 2 ) page: 358 - 369   2023.5

     More details

    Language:English  

    DOI: 10.1002/jha2.677

    PubMed

  2. Impact of HLA Epitope Matching on Outcomes After Unrelated Bone Marrow Transplantation.

    Iwasaki M, Kanda J, Tanaka H, Shindo T, Sato T, Doki N, Fukuda T, Ozawa Y, Eto T, Uchida N, Katayama Y, Kataoka K, Ara T, Ota S, Onizuka M, Kanda Y, Ichinohe T, Atsuta Y, Morishima S

    Frontiers in immunology   Vol. 13   page: 811733   2022

     More details

    Language:English  

    DOI: 10.3389/fimmu.2022.811733

    PubMed

  3. Assessment of cellular response to mitogens in long-term allogeneic hematopoietic stem cell transplantation survivors.

    Sato T, Goto M, Ohbiki M, Goto T, Morishita T, Seto A, Ozawa Y, Miyamura K

    International journal of hematology   Vol. 114 ( 6 ) page: 682 - 690   2021.12

     More details

    Authorship:Lead author, Corresponding author   Language:English  

    DOI: 10.1007/s12185-021-03206-7

    PubMed

  4. A Phase I/II Multicenter Trial of HLA-Haploidentical PBSCT with PTCy for Aggressive Adult T Cell Leukemia/Lymphoma.

    Tanaka T, Nakamae H, Ito A, Fuji S, Hirose A, Eto T, Henzan H, Takase K, Yamasaki S, Makiyama J, Moriuchi Y, Choi I, Nakano N, Hiramoto N, Kato K, Sato T, Sawayama Y, Kim SW, Inoue Y, Inamoto Y, Fukuda T

    Transplantation and cellular therapy   Vol. 27 ( 11 ) page: 928.e1 - 928.e7   2021.11

     More details

    Language:English  

    DOI: 10.1016/j.jtct.2021.07.010

    PubMed

  5. A case of sporadic late-onset nemaline myopathy with monoclonal gammopathy of undetermined significance: long-term observation of neurological symptoms after autologous stem-cell transplantation.

    Ando T, Sato T, Kurahashi S, Kawaguchi Y, Kagaya Y, Ozawa Y, Hirano S, Goto Y, Mano K, Yokoi S, Nakamura T, Murakami A, Noda S, Kimura S, Sone J, Kuru S, Sobue G, Katsuno M

    Nagoya journal of medical science   Vol. 83 ( 3 ) page: 641 - 647   2021.8

     More details

    Language:English  

    DOI: 10.18999/nagjms.83.3.641

    PubMed

  6. Novel anti-GARP antibody DS-1055a augments anti-tumor immunity by depleting highly suppressive GARP+ regulatory T cells.

    Satoh K, Kobayashi Y, Fujimaki K, Hayashi S, Ishida S, Sugiyama D, Sato T, Lim K, Miyamoto M, Kozuma S, Kadokura M, Wakita K, Hata M, Hirahara K, Amano M, Watanabe I, Okamoto A, Tuettenberg A, Jonuleit H, Tanemura A, Maruyama S, Agatsuma T, Wada T, Nishikawa H

    International immunology   Vol. 33 ( 8 ) page: 435 - 446   2021.7

     More details

    Language:English  

    DOI: 10.1093/intimm/dxab027

    PubMed

  7. A case of reexpansion pulmonary edema and acute pulmonary thromboembolism associated with diffuse large B-cell lymphoma treated with venovenous extracorporeal membrane oxygenation.

    Kazama S, Hiraiwa H, Kimura Y, Ozaki R, Shibata N, Arao Y, Oishi H, Kato H, Kuwayama T, Yamaguchi S, Kondo T, Furusawa K, Morimoto R, Okumura T, Bando YK, Sato T, Shimada K, Kiyoi H, Nakamura G, Yasuda Y, Kasugai D, Ogawa H, Higashi M, Yamamoto T, Jingushi N, Ozaki M, Numaguchi A, Goto Y, Matsuda N, Murohara T

    Journal of cardiology cases   Vol. 23 ( 1 ) page: 53 - 56   2021.1

     More details

    Language:English  

    DOI: 10.1016/j.jccase.2020.08.013

    PubMed

  8. Day 0 bone marrow pathology of allogeneic hematopoietic stem cell transplantation is a novel prognostic factor in myeloid malignancies.

    Sato T, Kawashima N, Ito M, Atsuta Y, Kagaya Y, Seto A, Morishita T, Fukushima N, Ozawa Y, Miyamura K

    Blood cell therapy   Vol. 3 ( 4 ) page: 84 - 91   2020.11

     More details

    Authorship:Lead author   Language:English  

    DOI: 10.31547/bct-2020-007

    PubMed

  9. Higher Peak Tacrolimus Concentrations after Allogeneic Hematopoietic Stem Cell Transplantation Increase the Risk of Endothelial Cell Damage Complications.

    Morishita T, Okabe M, Kawaguchi Y, Lee Y, Ohbiki M, Osaki M, Goto M, Araie H, Sato T, Goto T, Ozawa Y, Miyamura K

    Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation   Vol. 24 ( 12 ) page: 2509 - 2516   2018.12

     More details

    Language:English  

    DOI: 10.1016/j.bbmt.2018.07.029

    PubMed

  10. Iodine staining and p16 immunohistochemistry as a novel screening for secondary esophageal neoplasm after hematopoietic stem cell transplantation.

    Sato T, Seto A, Kagaya Y, Kawashima N, Koyama D, Morishita T, Ozawa Y, Miyamura K, Yamaguchi T, Haruta JI, Ito M

    Bone marrow transplantation   Vol. 53 ( 10 ) page: 1359 - 1363   2018.10

     More details

    Authorship:Lead author   Language:English  

    DOI: 10.1038/s41409-018-0197-2

    PubMed

  11. Successful treatment with allogeneic stem cell transplantation followed by DLI and TKIs for e6a2 BCR-ABL-positive acute myeloid leukaemia: A case report and literature review.

    Harada Y, Nishiwaki S, Sugimoto T, Onodera K, Goto T, Sato T, Kamoshita S, Kawashima N, Seto A, Okuno S, Yamamoto S, Iwasaki T, Ozawa Y, Miyamura K, Akatsuka Y, Sugiura I

    Medicine   Vol. 96 ( 50 ) page: e9160   2017.12

     More details

    Language:English  

    DOI: 10.1097/MD.0000000000009160

    PubMed

  12. Long-term outcomes of allogeneic hematopoietic cell transplantation with intensified myeloablative conditioning for refractory myeloid malignancy.

    Kawashima N, Inamoto Y, Sato T, Nakashima M, Kagaya Y, Watakabe K, Seto A, Fukushima N, Kurahashi S, Ozawa Y, Miyamura K

    Bone marrow transplantation   Vol. 51 ( 6 ) page: 869 - 71   2016.6

     More details

    Language:English  

    DOI: 10.1038/bmt.2016.15

    PubMed

  13. Counterbalance between RB inactivation and miR-17-92 overexpression in reactive oxygen species and DNA damage induction in lung cancers.

    Ebi H, Sato T, Sugito N, Hosono Y, Yatabe Y, Matsuyama Y, Yamaguchi T, Osada H, Suzuki M, Takahashi T

    Oncogene   Vol. 28 ( 38 ) page: 3371 - 9   2009.9

     More details

    Authorship:Lead author   Language:English  

    DOI: 10.1038/onc.2009.201

    PubMed

  14. Relationship of deregulated signaling converging onto mTOR with prognosis and classification of lung adenocarcinoma shown by two independent in silico analyses.

    Ebi H, Tomida S, Takeuchi T, Arima C, Sato T, Mitsudomi T, Yatabe Y, Osada H, Takahashi T

    Cancer research   Vol. 69 ( 9 ) page: 4027 - 35   2009.5

     More details

    Language:English  

    DOI: 10.1158/0008-5472.CAN-08-3403

    PubMed

▼display all